España
ARRY
Locura total en PM (y aún le quedan casi 2 horas...), de 6,55 a 9,35
ESPR
Otra que tal, recuperando lo perdido el viernes, ya en los 30$ (+27%)
FDA Confims LDL-C lowering program is adequate to support approval of an LDL-C lowering indication for bempedoic acid
CERU
Si aún las llevas hay jaleo
Cerulean Pharma and Daré Bioscience Enter into Stock Purchase Agreement
http://ir.ceruleanrx.com/releasedetail.cfm?ReleaseID=1017982
Transaction to create NASDAQ-listed company focused on the development and commercialization of women's reproductive health products
Sabrina Martucci Johnson to be Named CEO of Combined Company
Cerulean and Daré to Host Joint Conference Call in March to Discuss Proposed Transaction and Dare's Business Opportunity
Cerulean Enters into Two Agreements to Sell Assets
Cerulean Pays off Debt Facility and Announces Reduction in Force
ESPR
Estuve a punto de vender el viernes tras las news de AMGN, menos mal que no!
FDA on board with Esperion's late-stage development program for bad cholesterol-lowering claim for bempedoic acid; shares ahead 33% premarket
http://www.seekingalpha.com/news/3252194
Vendí hace mucho, cuando tocó los 3 pensé en solución pronto, pero esto ya es otro tema.
Rgls estoy en esta, esperando que cierre el gap.
ATHX
The Lancet Neurology. The article highlights the feasibility and safety of intravenous MultiStem treatment for patients who have suffered a moderate to severe stroke, the progressive improvements in recovery experienced by these patients through one year, and the increased benefit for those patients receiving MultiStem treatment within 36 hours of their stroke. In addition, the article describes how patients receiving intravenous MultiStem treatment demonstrated a significant reduction in inflammatory cytokines and immune cells and a decrease in infections associated with immunodepression, compared to patients receiving placebo
«Después de nada, o después de todo/ supe que todo no era más que nada.»
CEMP parece que despega....que conste que estoy dentro gracias a las observaciones y argumentos de Zokatira 😉.....
Pd....esta tapará las heridas de DRYS...espero...quien me mandará meterme en barcos ...
CEMP
Disparada hoy
4.18 +0.33 (+8.44%)
sin news que yo conozca
Despegando desde hace varios dias atras, alquien sabe por qué.? Lo ultima noticia solo mencionaba que habia escogido a Morgan Stanley como su asesor financiero
Jjjjj hemos estado escribiendo a la vez ....CEMP , eso sí , tu las llevas a 3,60 y yo a 3,70....eso me dice mi sistema 🤔
